| Literature DB >> 29431424 |
Abstract
We discuss how the recent revelation that gadolinium (Gd) from commercially available MRI contrast agents is irreversibly and cumulatively deposited in the central nervous system is driving innovation toward Gd-free contrast agents for neuroradiology.Entities:
Keywords: GBCA; Gadolinium; central nervous system; magnetic resonance imaging
Mesh:
Substances:
Year: 2018 PMID: 29431424 PMCID: PMC5994911 DOI: 10.1021/acschemneuro.8b00044
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418